Isomorphic Labs in talks to raise about $5B at a $50B valuation

Isomorphic Labs, the Alphabet company spun out of Google DeepMind, is negotiating a raise of about $5B at a valuation of about $50B, according to Bloomberg, as reported by Rohan Paul on X. The company has no drug yet tested in people.

It sells a drug-design engine built on AlphaFold 3, which predicts how proteins fold and how candidate molecules bind them, so chemists can rank designs on a computer before synthesis and animal studies. The fact record does not state whether the talks have closed.